Literature DB >> 24768485

Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor.

Zhan-Qiang Jin1, Mei-Ying Lin2, Wen-Hua Hu3, Wei-Yong Li4, Shao-Jun Bai5.   

Abstract

Ultrasonography (US) is the preferred imaging modality for papillary thyroid microcarcinoma (PTMC). The aim of this study was to evaluate the importance of gray-scale ultrasound combined with elastography to predict extrathyroidal extension and cervical lymph node (LN) metastasis in patients with PTMC. We retrospectively evaluated gray-scale ultrasonic and elastographic results from 119 consecutive cases of PTMC with 138 nodules and correlated the histopathological findings. The results indicated that pathological extrathyroidal extension was significantly associated with T staging on US, extrathyroidal extension on US, bilaterality on US, boundary, strain ratio and hard malignancy as measured with the Rago score. Central LN metastasis on pathology was significantly associated with central LN metastasis on US, lateral LN metastasis on US, multifocality on US and bilaterality on US. Lateral LN metastasis on US was significantly associated with lateral LN metastasis on pathology. On multivariate analysis, T staging on US, extrathyroidal extension on US and hard malignancy as measured with the Rago score were significantly associated with pathological extrathyroidal extension. Lateral LN metastasis on US and bilaterality on US were independent factors in predicting central LN metastasis on pathology. Lateral LN metastasis on US was the predictive factor for lateral LN metastasis on pathology. US should be helpful in the diagnosis of PTMC and in the evaluation of possible PTMC recurrence on US in routine clinical practice.
Copyright © 2014 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinicopathology; Elastography; Papillary thyroid microcarcinoma; Prognostic factor; Ultrasonography

Mesh:

Year:  2014        PMID: 24768485     DOI: 10.1016/j.ultrasmedbio.2014.02.015

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

Review 1.  The diagnostic performance of shear wave elastography for malignant cervical lymph nodes: A systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Young Jun Choi; Jung Hwan Baek; Jeong Hyun Lee
Journal:  Eur Radiol       Date:  2016-05-05       Impact factor: 5.315

Review 2.  Updated guidelines on the preoperative staging of thyroid cancer.

Authors:  Hye Jung Kim
Journal:  Ultrasonography       Date:  2017-04-09

3.  Association Between Preoperative US, Elastography Features and Prognostic Factors of Papillary Thyroid Cancer With BRAFV600E Mutation.

Authors:  Jun-Mei Xu; Yong-Jun Chen; Yuan-Yuan Dang; Man Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-22       Impact factor: 5.555

4.  Diagnostic value of routine ultrasonography combined with ultrasound elastography for papillary thyroid microcarcinoma: A protocol for systematic review and meta-analysis.

Authors:  Yanfei Du; Yuyan Jiang; Shujuan Tang; Lijie Li
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

5.  Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.

Authors:  Chunwang Huang; Shuzhen Cong; Shiyao Shang; Manli Wang; Huan Zheng; Suqing Wu; Xiuyan An; Zhaoqiu Liang; Bo Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-07       Impact factor: 5.555

6.  A Risk Model for Predicting Central Lymph Node Metastasis of Papillary Thyroid Microcarcinoma Including Conventional Ultrasound and Acoustic Radiation Force Impulse Elastography.

Authors:  Jun-Mei Xu; Hui-Xiong Xu; Xiao-Long Li; Xiao-Wan Bo; Xiao-Hong Xu; Yi-Feng Zhang; Le-Hang Guo; Lin-Na Liu; Shen Qu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.